Nuclear factor-κB-dependent expression of metastasis suppressor KAI1/CD82 gene in lung cancer cell lines expressing mutant p53

Cancer Research

Volumn 61, Issue 2, 2001, Pages 673-678

  Shinohara, Tsutomu ^a   Miki, Toyokazu ^a   Nishimura, Naoki ^a   Nokihara, Hiroshi ^a   Hamada, Hirofumi ^c   Mukaida, Naofumi ^b   Sone, Saburo ^a  

^a UNIVERSITY OF TOKUSHIMA   (Japan)

^b KANAZAWA UNIVERSITY   (Japan)

^c SAPPORO MEDICAL UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CD82 ANTIGEN; DNA BINDING PROTEIN; I KAPPA B; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; KAI1 PROTEIN, HUMAN; LEUKOCYTE ANTIGEN; MEMBRANE PROTEIN; NF KAPPAB INHIBITOR ALPHA; NF-KAPPAB INHIBITOR ALPHA; ONCOPROTEIN; PROTEIN P53; PYRROLIDINE DERIVATIVE; PYRROLIDINE DITHIOCARBAMIC ACID; RNA; THIOCARBAMIC ACID DERIVATIVE; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR;

ARTICLE; CELL CULTURE; DRUG EFFECT; FLOW CYTOMETRY; GENE EXPRESSION REGULATION; GENETIC TRANSFECTION; GENETICS; HUMAN; LUNG TUMOR; METABOLISM; MUTATION; PATHOLOGY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; UPREGULATION; WESTERN BLOTTING; CONTROLLED STUDY; GENE ACTIVATION; GENE TRANSFER; HUMAN CELL; LUNG CANCER; METASTASIS SUPPRESSOR GENE; PRIORITY JOURNAL; TUMOR SUPPRESSOR GENE;

ANTIGENS, CD; BLOTTING, WESTERN; DNA-BINDING PROTEINS; FLOW CYTOMETRY; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; I-KAPPA B PROTEINS; KANGAI-1 PROTEIN; LUNG NEOPLASMS; MEMBRANE GLYCOPROTEINS; MUTATION; NF-KAPPA B; PROTO-ONCOGENE PROTEINS; PYRROLIDINES; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, NEOPLASM; THIOCARBAMATES; TRANSFECTION; TUMOR CELLS, CULTURED; TUMOR NECROSIS FACTOR-ALPHA; TUMOR SUPPRESSOR PROTEIN P53; UP-REGULATION;

EID: 0035862151     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (48)

1. The ins and outs of the transmembrane 4 superfamily
2. KAI1, a metastasis suppressor gene for prostate cancer of human chromosome llpll.2
3. Down-regulation of KAI1 metastasis suppressor gene during the progression of human prostatic cancer infrequently involves gene mutation or allelic loss
4. KAI1 expression is up-regulated in early pancreatic cancer and decreased in the presence of metastases
5. Correlation of KAI1/CD82 gene expression with good prognosis in patients with non-small cell lung cancer
6. The expression of the KAI1 gene, a tumor metastasis suppressor, is directly activated by p53
7. Tumor necrosis factor: A pleiotropic cytokine and therapeutic target
8. The role of TNF in tumor growth and metastasis
9. Function and activation of NF-kB in the immune system
10. Evidence for differential functions of p50 and p65 subunits of NF-κB with a cell adhesion model
11. NF-κB, and IκBα; an inducible regulatory system in endothelial activation
12. Nuclear factor-κB-a pivotal transcription factor in chronic inflammatory diseases
13. A cytokine-responsive IκB kinase that activates the transcription factor NF-κB
14. Control of IκB-a proteolysis by site-specific, signal-induced phosphorylation
15. Coupling of a signal response domain in IκBα to multiple pathways for NF-κB activation
16. Functional analysis of CD82 in the early phase of T cell activation: Roles in cell adhesion and signal transduction
17. A member of the tetra spans transmembrane protein supeffamily is recognized by a mAb raised against an HLA class 1-deficient, lymphokine-activated killer-susceptible, B lymphocyte line
18. Cisplatin-induced apoptosis and p53 gene status in a cisplatin-resistant human ovarian carcinoma cell line
19. Evolutionary conservation in the untranslated regions of actin mRNA: DNA sequence of a human ß-actin cDNA
20. Multiple nuclear factors interact with the immunoglobulin enhancer sequences
21. Genomic organization of the human KAI1 metastasis-suppressor gene
22. Accurate transcription initiation by RNA polymerase II in a soluble extract from isolated mammalian nuclei
23. Analysis of antibodies to pl6INK4A tumor suppressor gene products in lung cancer patients
24. Dithioearbamates as potent inhibitors of nuclear factor κB activation in intact cells
25. NF-κB activation of p53
26. Comprehensive analysis of p53 gene mutation characteristics in lung carcinoma with special reference to histological subtypes
27. New insights into p53 function from structural studies
28. Screening the p53 status of human cell lines using a yeast functional assay
29. Retinoic acid is a negative regulator of AP-l-responsive genes
30. Cross-coupling of the NF-κB p65 and Fos/Jun transcription factors produces potentiated biological function
31. Inducibility of κ immunoglobulin enhancer-binding protein NF-kB by a posttranslational mechanism
32. Topoisomerase poisons activate the transcription factor NF-κB in ACH2 and CEM cells
33. Activation of NF-κB by antineoplastic agents
34. Control of inducible chemoresistance: Enhanced anti-tumor therapy through increased apoptosis by inhibition of NF-κB
35. Ionizing radiation induces expression and binding activity of the nuclear factor κ
36. Inhibition of nuclear factor-κB activity is involved in E1A-mediated sensitization of radiation-induced apoptosis
37. TNF- and cancer therapy-induced apoptosis: Potentiation by inhibition of NF-κB
38. NF-κB antiapoptosis: Induction of TRAFI and TRAF2 and c-IAP1 and c-IAP2 to suppress caspase-8 activation
39. Disruption of l-κ-B-α regulation by antisense RNA expression leads to malignant transformation
40. Suppression of cell motility and metastasis by transfection with human motility-related protein (MRP-I/CD9) DNA
41. Platelet activation by immobilized monoclonai antibody: Evidence for a CD9 proximal signal
42. Anti-CD9 monoclonal antibody elicits staurosporine inhibitable phosphatidylinositol 4,5-bisphosphate hydrolysis, phosphatidylinositol 3,4-bisphosphate synthesis, and protein-tyrosine phosphorylation in human platelets
43. CD82, tetra-spantransmembrane protein, is a regulated transducing molecule on U937 monocytic cell line
44. Platelet activation by CD9 monoclonal antibodies is mediated by the Fc γ II receptor
45. Interleukin-4 suppression of tumor necrosis factor α-stimulated E-selectin gene transcription is mediated by STAT6 antagonism of nf-κB
46. Interleukin-10 signaling blocks inhibitor of κB kinase activity and nuclear factor κB DNA binding
47. Human non-small cell lung cancer cells express a type 2 cytokine pattern
48. KAI1 is unchanged in metastatic and nonmetastatie esophageal and gastric cancers